The literature has been reviewed to determine whether cephalosporins have been implicated in causing nephrotoxicity and to assess the influence of concomitant aminoglycoside therapy. Animal and human data have implicated cephaloridine and cephalothin in causing nephrotoxicity, both alone and in combination with aminoglycosides. There are few data implicating other cephalosporins in causing nephrotoxicity. Cefazolin, which is nephrotoxic in animals, has not been reported to produce nephrotoxicity in humans. Two studies have documented nephrotoxicity due to ceftazidime, especially in patients with preexisting renal impairment. Such patients should have their dosage adjusted to minimize ceftazidime-induced renal impairment. Finally, cephalosporins other than cephaloridine and cephalothin have not been documented to increase the risk of nephrotoxicity when used in combination with aminoglycosides compared with aminoglycosides alone.
Get full access to this article
View all access options for this article.
References
1.
CaldwellJR.CLUFF LE. Adverse reactions to antimicrobial agents. JAMA1974; 230: 77–80.
2.
AtkinsonRMCurrieJPDavisB.Acute toxicity of cephaloridine, an antibiotic derived from cephalosporin C. Toxicol Appl Pharmacol1966; 8: 398–406.
3.
WellesJSGibsonWRHarrisPNToxicity distribution and excretion of cephaloridine in laboratory animals. Antimicrob Agents Chemother1966; 1965: 863–9.
4.
TuneBM.Relationship between the transport and toxicity of cephalosporins in the kidney. J Infect Dis1975; 132: 189–94.
5.
TuneBMFravertD.Mechanisms of cephalosporin nephrotoxicity: a comparison of cephaloridine and cephaloglycin. Kidney Int1980; 18: 591–600.
6.
BarzaM.The nephrotoxicity of cephalosporins: an overview. J Infect Dis1978; 137 (suppl): S60–73.
7.
BennerEJ.Renal damage associated with prolonged administration of ampicillin, cephaloridine, and cephalothin. Antimicrob Agents Chemother1969; 9: 417–20.
8.
FoordRD.Cephaloridine, cephalothin and the kidney. J Antimicrob Chemother1975; 1 (suppl): 119–33.
9.
AppelGBNeuHCThe nephrotoxicity of antimicrobial agents. N Engl J Med1977; 296: 663–70.
10.
CooperK.BennetWMNephrotoxicity of common drugs used in clinical practice. Arch Intern Med1987; 147: 1213–8.
11.
RahalJJMeyersBRWeinsteinL.Treatment of bacterial endocarditis with cephalothin. N Engl J Med1968; 279: 1305–9.
12.
PickeringMJSpoonerGRQuesadaA.Declining renal function associated with administration of cephalothin. South Med J1970; 63: 426–8.
13.
BobrowSNJaffeE.YoungRCAnuria and acute tubular necrosis associated with gentamicin and cephalothin. JAMA1972; 222: 1546–7.
14.
BurtonJRLichtensteinNSColvinRBAcute renal failure during cephalothin therapy. JAMA1974; 229: 679–82.
15.
EngleJEDragoJ.CarlinB.Reversible acute renal failure after cephalothin. Ann Intern Med1975; 83: 232–3.
16.
CarlingPCIdelsonBACasanoAANephrotoxicity associated with cephalothin administration. Arch Intern Med1975; 135: 797–801.
SilverblattF.HarrisonWOTurckM.Nephrotoxicity of cephalosporin antibiotics in experimental animals. J Infect Dis1973; 182 (suppl): S367–72.
19.
KuninCMFinkelbergZ.Oral cephalexin and ampicillin: antimicrobial activity, recovery in urine, and persistence in blood of uremic patients. Ann Intern Med1970; 72: 349–56.
20.
Fung-HerreraCGMulvaneyWPCephalexin nephrotoxicity: reversible nonoliguric acute renal failure and hepatotoxicity associated with cephalexin therapy. JAMA1974; 229: 318–9.
21.
WoldJSWellesJSOwenNVToxicological evaluation of cefamandole nafate in laboratory animals. J Infect Dis1978; 137 (suppl): S51–9.
22.
BintAJBullockDWSpellerDCECefuroxime therapy for urinary tract infections caused by multi-resistant, epidemic Klebsiella aerogenes. J Antimicrob Chemother1979; 5: 189–93.
23.
ZhanelGGBrunhamRCThird-generation cephalosporins. Can J Hosp Pharm1988; 41: 183–94.
24.
NorrbySRBurmanLAUnderholmH.Ceftazidime: pharmacokinetics in patients and effects on the renal function. J Antimicrob Chemother1982; 10: 199–206.
25.
AlestigK.TrollforsB.AndersonR.Ceftazidime and renal function. J Antimicrob Chemother1984; 13: 177–81.
26.
KleinknechtD.GanevalD.DrozD.Acute renal failure after high doses of gentamicin and cephalothin. Lancet1973; 1: 1129.
27.
GayaH.KlasterskyJ.SchimpffSCNephrotoxicity during combined therapy with gentamicin and cephalothin (abstract). In: Program and abstracts of the 15th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1975: 401.
28.
KlasterskyJ.HansgensC.DebusscherL.Empiric therapy for cancer patients: comparative study of ticarcillin-tobramycin, ticarcillin-cephalothin, and cephalothin-tobramycin. Antimicrob Agents Chemother1975; 7: 640–5.
29.
FanningWLGumpD.JickH.Gentamicin- and cephalothin-associated rises in blood urea nitrogen. Antimicrob Agents Chemother1976; 10: 80–2.
30.
LuftFCPatelV.YumMNNephrotoxicity of cephalosporin-gentamicin combinations in rats. Antimicrob Agents Chemother1976; 9: 831–9.
